EUVIMEDEUVIMED entdecken
Crossref

VISTA deficiency exerts anti-tumor effects in breast cancer through regulating macrophage polarization

Shasha Jin, Wanmei Liu, Xiaoyu He, Yuxin Zhang, Wenting Chen, Yinhao Wu, Jun Liu

International Immunopharmacology · 2024-07 · 136 · 112365

DOI: 10.1016/j.intimp.2024.112365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-07. Verfasst von Shasha Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Screening Center, China Pharmaceutical University, Nanjing 210009, China. Hauptthemen laut MEDLINE: Breast Neoplasms, STAT6 Transcription Factor, STAT1 Transcription Factor, Tumor-Associated Macrophages. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growing evidence had showed that tumor-associated macrophages (TAMs) have a tumor-promoting M2 phenotype which could drive pathological phenomena. In breast cancer, TAMs are abundantly present and may play an important role in the development of breast cancer. V-domain immunoglobulin suppressor of T cell activation (VISTA) is a novel inhibitory checkpoint and immunotherapy target for tumor through regulating immune response. However, its effects on macrophages have not been investigated, which was also the focus of this study. Here, the scRNA-seq data further revealed that VISTA was highly expressed in multiple macrophage subclusters. In vitro experiments showed that the absence of VISTA enhanced the M1 polarization of macrophages, inhibited the M2 polarization of macrophages and the proliferation and phagocytosis of 4 T1 cells induced by M2-CM. VISTA regulated the activation of STAT1 and STAT6 signaling pathways in the process of macrophage polarization. In vivo experiments demonstrated that VISTA deficient mice exhibited reduced tumor growth, possibly due to the increase of M1 macrophages and the decrease of M2 macrophages. In summary, our study is the first to reveal the effect of VISTA on macrophages in breast cancer, which showed that VISTA affects tumor growth by critically regulating the macrophage polarization through the STAT pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsSTAT6 Transcription FactorSTAT1 Transcription FactorTumor-Associated MacrophagesAnimalsFemaleMiceHumansB7 AntigensMice, KnockoutCell Line, TumorMacrophagesSignal TransductionMacrophage ActivationPhagocytosisCell ProliferationMice, Inbred C57BLMembrane Proteins

Stichwörter der Autor:innen

Breast cancerImmunotherapyMacrophagePolarizationVISTA

Substanzen

STAT6 Transcription FactorSTAT1 Transcription FactorB7 AntigensVsir protein, mouseVSIR protein, humanStat6 protein, mouseStat1 protein, mouseMembrane Proteins

Autor:innen und Institutionen

  • New Drug Screening Center, China Pharmaceutical University, Nanjing 210009, China.
  • New Drug Screening Center, China Pharmaceutical University, Nanjing 210009, China. Electronic address: junliu@cpu.edu.cn.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Jin, S., Liu, W., He, X., Zhang, Y., Chen, W., Wu, Y., & Liu, J. (2024). VISTA deficiency exerts anti-tumor effects in breast cancer through regulating macrophage polarization. International Immunopharmacology, 136, 112365. https://doi.org/10.1016/j.intimp.2024.112365

Vancouver

Jin S, Liu W, He X, Zhang Y, Chen W, Wu Y, et al. VISTA deficiency exerts anti-tumor effects in breast cancer through regulating macrophage polarization. International Immunopharmacology. 2024;136:112365. doi:10.1016/j.intimp.2024.112365

BibTeX
@article{Jin2024,
  author = {Jin, Shasha and Liu, Wanmei and He, Xiaoyu and Zhang, Yuxin and Chen, Wenting and Wu, Yinhao and Liu, Jun},
  title = {VISTA deficiency exerts anti-tumor effects in breast cancer through regulating macrophage polarization},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {136},
  pages = {112365},
  doi = {10.1016/j.intimp.2024.112365}
}
Kostenlos starten →